Trial intelligence / Profile preview

Microneedle patch with triamcinolone acetonide and hydrocortisone for inflammatory acne

TCTR20220830003Phase 3Recruiting

Sponsor
National Research Council of Thailand
Start
Sep 2022
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of triamcinolone acetonide, hydrocortisone in acne vulgaris, sponsored by National Research Council of Thailand. Started Sep 2022; status: recruiting.

02

Drugs

triamcinolone acetonidehydrocortisone
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on TCTR20220830003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20220830003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call